Genetic association study of the P300 endophenotype in schizophrenia

Schizophrenia Research

Volumn 141, Issue 1, 2012, Pages 54-59

  Decoster, Jeroen ^a,b   De Hert, Marc ^a   Viechtbauer, Wolfgang ^a   Nagels, Guy ^a,d   Myin Germeys, Inez ^b   Peuskens, Jos ^a   van Os, Jim ^b,c   van Winkel, Ruud ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF MONS   (Belgium)

Author keywords

ABCB1 gene; Event related potential (ERP); Intermediate phenotype; P glycoprotein; P300; Schizophrenia

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; BRAIN DERIVED NEUROTROPHIC FACTOR; BUTYROPHENONE; CLOZAPINE; DIPHENYLBUTYLPIPERIDINE DERIVATIVE; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; MICRORNA; MICRORNA 137; MULTIDRUG RESISTANCE PROTEIN 1; OLANZAPINE; PHENOTHIAZINE; QUETIAPINE; RISPERIDONE; THIOXANTHENE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; DISEASE DURATION; ELECTRODE; ENDOPHENOTYPE; EVENT RELATED POTENTIAL; FEMALE; GENDER; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; PARIETAL LOBE; PRIORITY JOURNAL; SAMPLE SIZE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ELECTROENCEPHALOGRAPHY; ENDOPHENOTYPES; EVENT-RELATED POTENTIALS, P300; FEMALE; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; P-GLYCOPROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84865968194     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.07.018     Document Type: Article

References (47)

1. Allen N.C., Bagade S., McQueen M.B., Ioannidis J.P., Kavvoura F.K., Khoury M.J., Tanzi R.E., Bertram L. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet. 2008, 40(7):827-834.
2. Antolin T., Berman S.M., Conner B.T., Ozkaragoz T.Z., Sheen C.L., Ritchie T.L., Noble E.P. D2 dopamine receptor (DRD2) gene, P300, and personality in children of alcoholics. Psychiatry Res. 2009, 166(2-3):91-101.
3. Berman S.M., Noble E.P., Antolin T., Sheen C., Conner B.T., Ritchie T. P300 development during adolescence: effects of DRD2 genotype. Clin. Neurophysiol. 2006, 117(3):649-659.
4. Bestelmeyer P.E., Phillips L.H., Crombie C., Benson P., St Clair D. The P300 as a possible endophenotype for schizophrenia and bipolar disorder: evidence from twin and patient studies. Psychiatry Res. 2009, 169(3):212-219.
5. Blackwood D.H., Fordyce A., Walker M.T., St Clair D.M., Porteous D.J., Muir W.J. Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am. J. Hum. Genet. 2001, 69(2):428-433.
6. Bonhomme-Faivre L., Benyamina A., Reynaud M., Farinotti R., Abbara C. Disposition of Delta tetrahydrocannabinol in CF1 mice deficient in mdr1a P-glycoprotein. Addict. Biol. 2008, 13(3-4):295-300.
7. Bramon E., McDonald C., Croft R.J., Landau S., Filbey F., Gruzelier J.H., Sham P.C., Frangou S., Murray R.M. Is the P300 wave an endophenotype for schizophrenia? A meta-analysis and a family study. Neuroimage 2005, 27(4):960-968.
8. Bramon E., Dempster E., Frangou S., McDonald C., Schoenberg P., MacCabe J.H., Walshe M., Sham P., Collier D., Murray R.M. Is there an association between the COMT gene and P300 endophenotypes?. Eur. Psychiatry 2006, 21(1):70-73.
9. Bramon E., Dempster E., Frangou S., Shaikh M., Walshe M., Filbey F.M., McDonald C., Sham P., Collier D.A., Murray R. Neuregulin-1 and the P300 waveform-a preliminary association study using a psychosis endophenotype. Schizophr. Res. 2008, 103(1-3):178-185.
10. Chen T.J., Yu Y.W., Chen J.Y., Wang Y.C., Chen M.C., Hong C.J., Tsai S.J. Association analysis of two dopamine D2 receptor gene polymorphisms and p300 event-related potential in depressive patients. Neuropsychobiology 2002, 46(3):141-144.
11. Cordell H.J., Clayton D.G. Genetic association studies. Lancet 2005, 366(9491):1121-1131.
12. De Hert M., Dekker J.M., Wood D., Kahl K.G., Holt R.I., Moller H.J. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur. Psychiatry 2009, 24(6):412-424.
13. De Hert M., van Winkel R., Silic A., Van Eyck D., Peuskens J. Physical health management in psychiatric settings. Eur. Psychiatry 2010, 25(Suppl. 2):S22-28.
14. Gallinat J., Bajbouj M., Sander T., Schlattmann P., Xu K., Ferro E.F., Goldman D., Winterer G. Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biol. Psychiatry 2003, 54(1):40-48.
15. Gallinat J., Gotz T., Kalus P., Bajbouj M., Sander T., Winterer G. Genetic variations of the NR3A subunit of the NMDA receptor modulate prefrontal cerebral activity in humans. J. Cogn. Neurosci. 2007, 19(1):59-68.
16. Golimbet V., Gritsenko I., Alfimova M., Lebedeva I., Lezheiko T., Abramova L., Kaleda V., Ebstein R. Association study of COMT gene Val158Met polymorphism with auditory P300 and performance on neurocognitive tests in patients with schizophrenia and their relatives. World J. Biol. Psychiatry 2006, 7(4):238-245.
17. Greenwood T.A., Lazzeroni L.C., Murray S.S., Cadenhead K.S., Calkins M.E., Dobie D.J., Green M.F., Gur R.E., Gur R.C., Hardiman G., Kelsoe J.R., Leonard S., Light G.A., Nuechterlein K.H., Olincy A., Radant A.D., Schork N.J., Seidman L.J., Siever L.J., Silverman J.M., Stone W.S., Swerdlow N.R., Tsuang D.W., Tsuang M.T., Turetsky B.I., Freedman R., Braff D.L. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am. J. Psychiatry 2011, 168(9):930-946.
18. Hall M.H., Rijsdijk F., Picchioni M., Schulze K., Ettinger U., Toulopoulou T., Bramon E., Murray R.M., Sham P. Substantial shared genetic influences on schizophrenia and event-related potentials. Am. J. Psychiatry 2007, 164(5):804-812.
19. Hall M.H., Schulze K., Rijsdijk F., Kalidindi S., McDonald C., Bramon E., Murray R.M., Sham P. Are auditory P300 and duration MMN heritable and putative endophenotypes of psychotic bipolar disorder? A Maudsley Bipolar Twin and Family Study. Psychol. Med. 2009, 39(8):1277-1287.
20. Hansell N.K., James M.R., Duffy D.L., Birley A.J., Luciano M., Geffen G.M., Wright M.J., Montgomery G.W., Martin N.G. Effect of the BDNF V166M polymorphism on working memory in healthy adolescents. Genes Brain Behav. 2007, 6(3):260-268.
21. Hill S.Y., Locke J., Zezza N., Kaplan B., Neiswanger K., Steinhauer S.R., Wipprecht G., Xu J. Genetic association between reduced P300 amplitude and the DRD2 dopamine receptor A1 allele in children at high risk for alcoholism. Biol. Psychiatry 1998, 43(1):40-51.
22. Johnson J.P., Muhleman D., MacMurray J., Gade R., Verde R., Ask M., Kelley J., Comings D.E. Association between the cannabinoid receptor gene (CNR1) and the P300 event-related potential. Mol. Psychiatry 1997, 2(2):169-171.
23. Kimchi-Sarfaty C., Oh J.M., Kim I.W., Sauna Z.E., Calcagno A.M., Ambudkar S.V., Gottesman M.M. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 2007, 315(5811):525-528.
24. Liu J., Kiehl K.A., Pearlson G., Perrone-Bizzozero N.I., Eichele T., Calhoun V.D. Genetic determinants of target and novelty-related event-related potentials in the auditory oddball response. Neuroimage 2009, 46(3):809-816.
25. Moons T., de Roo M., Claes S., Dom G. Relationship between P-glycoprotein and second-generation antipsychotics. Pharmacogenomics 2011, 12(8):1193-1211.
26. Mulert C., Juckel G., Giegling I., Pogarell O., Leicht G., Karch S., Mavrogiorgou P., Moller H.J., Hegerl U., Rujescu D. A Ser9Gly polymorphism in the dopamine D3 receptor gene (DRD3) and event-related P300 potentials. Neuropsychopharmacology 2006, 31(6):1335-1344.
27. O'Connor S., Morzorati S., Christian J.C., Li T.K. Heritable features of the auditory oddball event-related potential: peaks, latencies, morphology and topography. Electroencephalogr. Clin. Neurophysiol. 1994, 92(2):115-125.
28. Osborne J.W., Overbay A. The power of outliers (and why researchers should always check for them). Practical Assess. Res. Eval. 2004, 9(6).
29. Ripke S., Sanders A.R., Kendler K.S., Levinson D.F., Sklar P., Holmans P.A., Lin D.Y., Duan J., Ophoff R.A., Andreassen O.A., Scolnick E., Cichon S., St Clair D., Corvin A., Gurling H., Werge T., Rujescu D., Blackwood D.H., Pato C.N., Malhotra A.K., Purcell S., Dudbridge F., Neale B.M., Rossin L., Visscher P.M., Posthuma D., Ruderfer D.M., Fanous A., Stefansson H., Steinberg S., Mowry B.J., Golimbet V., De Hert M., Jonsson E.G., Bitter I., Pietilainen O.P., Collier D.A., Tosato S., Agartz I., Albus M., Alexander M., Amdur R.L., Amin F., Bass N., Bergen S.E., Black D.W., Borglum A.D., Brown M.A., Bruggeman R., Buccola N.G., Byerley W.F., Cahn W., Cantor R.M., Carr V.J., Catts S.V., Choudhury K., Cloninger C.R., Cormican P., Craddock N., Danoy P.A., Datta S., de Haan L., Demontis D., Dikeos D., Djurovic S., Donnelly P., Donohoe G., Duong L., Dwyer S., Fink-Jensen A., Freedman R., Freimer N.B., Friedl M., Georgieva L., Giegling I., Gill M., Glenthoj B., Godard S., Hamshere M., Hansen M., Hansen T., Hartmann A.M., Henskens F.A., Hougaard D.M., Hultman C.M., Ingason A., Jablensky A.V., Jakobsen K.D., Jay M., Jurgens G., Kahn R.S., Keller M.C., Kenis G., Kenny E., Kim Y., Kirov G.K., Konnerth H., Konte B., Krabbendam L., Krasucki R., Lasseter V.K., Laurent C., Lawrence J., Lencz T., Lerer F.B., Liang K.Y., Lichtenstein P., Lieberman J.A., Linszen D.H., Lonnqvist J., Loughland C.M., Maclean A.W., Maher B.S., Maier W., Mallet J., Malloy P., Mattheisen M., Mattingsdal M., McGhee K.A., McGrath J.J., McIntosh A., McLean D.E., McQuillin A., Melle I., Michie P.T., Milanova V., Morris D.W., Mors O., Mortensen P.B., Moskvina V., Muglia P., Myin-Germeys I., Nertney D.A., Nestadt G., Nielsen J., Nikolov I., Nordentoft M., Norton N., Nothen M.M., O'Dushlaine C.T., Olincy A., Olsen L., O'Neill F.A., Orntoft T.F., Owen M.J., Pantelis C., Papadimitriou G., Pato M.T., Peltonen L., Petursson H., Pickard B., Pimm J., Pulver A.E., Puri V., Quested D., Quinn E.M., Rasmussen H.B., Rethelyi J.M., Ribble R., Rietschel M., Riley B.P., Ruggeri M., Schall U., Schulze T.G., Schwab S.G., Scott R.J., Shi J., Sigurdsson E., Silverman J.M., Spencer C.C., Stefansson K., Strange A., Strengman E., Stroup T.S., Suvisaari J., Terenius L., Thirumalai S., Thygesen J.H., Timm S., Toncheva D., van den Oord E., van Os J., van Winkel R., Veldink J., Walsh D., Wang A.G., Wiersma D., Wildenauer D.B., Williams H.J., Williams N.M., Wormley B., Zammit S., Sullivan P.F., O'Donovan M.C., Daly M.J., Gejman P.V. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 2011, 43(10):969-976.
30. Salisbury D.F., Shenton M.E., McCarley R.W. P300 topography differs in schizophrenia and manic psychosis. Biol. Psychiatry 1999, 45(1):98-106.
31. Schofield P.R., Williams L.M., Paul R.H., Gatt J.M., Brown K., Luty A., Cooper N., Grieve S., Dobson-Stone C., Morris C., Kuan S.A., Gordon E. Disturbances in selective information processing associated with the BDNF Val66Met polymorphism: evidence from cognition, the P300 and fronto-hippocampal systems. Biol. Psychol. 2009, 80(2):176-188.
32. Shaikh M., Hall M.H., Schulze K., Dutt A., Li K., Williams I., Walshe M., Constante M., Broome M., Picchioni M., Toulopoulou T., Collier D., Stahl D., Rijsdijk F., Powell J., Murray R.M., Arranz M., Bramon E. Effect of DISC1 on the P300 waveform in psychosis. Schizophr. Bull. 2011.
33. Souza V.B., Muir W.J., Walker M.T., Glabus M.F., Roxborough H.M., Sharp C.W., Dunan J.R., Blackwood D.H. Auditory P300 event-related potentials and neuropsychological performance in schizophrenia and bipolar affective disorder. Biol. Psychiatry 1995, 37(5):300-310.
34. StataCorp Stata/SE Statistical Software, Release 10 2007, StataCorp LP, College Station.
35. Sullivan P.F. Spurious genetic associations. Biol. Psychiatry 2007, 61(10):1121-1126.
36. Tsai S.J., Yu Y.W., Chen T.J., Chen J.Y., Liou Y.J., Chen M.C., Hong C.J. Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females. Neurosci. Lett. 2003, 338(2):123-126.
37. Tsai S.J., Yu Y.W., Chen T.J., Chen M.C., Hong C.J. Association analysis for dopamine D3 receptor, dopamine D4 receptor and dopamine transporter genetic polymorphisms and P300 event-related potentials for normal young females. Psychiatr. Genet. 2003, 13(1):51-53.
38. Turetsky B.I., Calkins M.E., Light G.A., Olincy A., Radant A.D., Swerdlow N.R. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr. Bull. 2007, 33(1):69-94.
39. Umbricht D.S., Bates J.A., Lieberman J.A., Kane J.M., Javitt D.C. Electrophysiological indices of automatic and controlled auditory information processing in first-episode, recent-onset and chronic schizophrenia. Biol. Psychiatry 2006, 59(8):762-772.
40. van Beijsterveldt C.E., van Baal G.C., Molenaar P.C., Boomsma D.I., de Geus E.J. Stability of genetic and environmental influences on P300 amplitude: a longitudinal study in adolescent twins. Behav. Genet. 2001, 31(6):533-543.
41. van der Stelt O., Belger A. Application of electroencephalography to the study of cognitive and brain functions in schizophrenia. Schizophr. Bull. 2007, 33(4):955-970.
42. van Tricht M.J., Nieman D.H., Koelman J.H., van der Meer J.N., Bour L.J., de Haan L., Linszen D.H. Reduced parietal P300 amplitude is associated with an increased risk for a first psychotic episode. Biol. Psychiatry 2011, 68(7):642-648.
43. van Winkel R., GROUP Investigators Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up. Arch Gen Psychiatry 2011, 68(2):148-157.
44. van Winkel R., De Hert M., Van Eyck D., Hanssens L., Wampers M., Scheen A., Peuskens J. Screening for diabetes and other metabolic abnormalities in patients with schizophrenia and schizoaffective disorder: evaluation of incidence and screening methods. J. Clin. Psychiatry 2006, 67(10):1493-1500.
45. van Winkel R., Rutten B.P., Peerbooms O., Peuskens J., van Os J., De Hert M. MTHFR and risk of metabolic syndrome in patients with schizophrenia. Schizophr. Res. 2010, 121(1-3):193-198.
46. Vogel C.I., Laucht M., Furtado E.F., Becker K., Schmidt M.H. Association of DRD4 exon III polymorphism with auditory P300 amplitude in 8-year-old children. J. Neural Transm. 2006, 113(12):1935-1941.
47. Wang Y., Hu Y., Fang Y., Zhang K., Yang H., Ma J., Xu Q., Shen Y. Evidence of epistasis between the catechol-O-methyltransferase and aldehyde dehydrogenase 3B1 genes in paranoid schizophrenia. Biol. Psychiatry 2009, 65(12):1048-1054.